C07J - Steroids - Patents Sitemap

More topics under "C07J - Steroids" (42,482)
C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
C07J 11 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3 (283)
C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764)
C07J 15 - Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, l-isomers (136)
C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111)
C07J 19 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring (362)
C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
C07J 33 - Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (413)
C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
C07J 61 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms (90)
C07J 63 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms (2,707)
C07J 65 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of two rings, each by one atom (2)
C07J 67 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of two rings, each by one atom (2)
C07J 69 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom (107)
C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018)
C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
C07J 73 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms (1,160)
C07J 75 - Processes for the preparation of steroids, in general (1,657)
C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)

Patents for C07J - Steroids (408)
05/2006
05/10/2006	CN1771256A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
04/2006
04/12/2006	EP1644009A2 Compositions and methods for increasing telomerase activity
04/06/2006	US20060074060 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer
03/2006
03/28/2006	US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides
03/16/2006	WO2005116047A3 2-substituted 17-imino estrogen compounds for cytoprotection
03/16/2006	WO2004085458A3 Steroid spirolactonization
03/08/2006	EP1631579A2 17beta-hydroxysteroid dehydrogenase inhibitors
02/2006
02/21/2006	US7002030 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
02/08/2006	EP1622924A2 8$g(b)-vinyl-11$g(b)-( g(v)-substituted)alkyl-estra-1,3,5(10)-trienes
01/2006
01/24/2006	CA2166090C Novel process for preparing 17.beta.-substituted 4-azaandrostane derivatives
01/12/2006	WO2006004412A1 Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
01/11/2006	EP1613641A2 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
12/2005
12/28/2005	EP1608670A1 Process for the production of tibolone
12/21/2005	EP1606306A2 Steroid spirolactonization
12/08/2005	WO2005116047A2 2-substituted 17-imino estrogen compounds for cytoprotection
12/08/2005	US20050272711 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
12/08/2005	CA2566373A1 2-substituted 17-imino estrogen compounds for cytoprotection
12/01/2005	US20050267086 Compounds and methods for cytoprotection
11/2005
11/23/2005	EP1598054A2 Method of suppressing appetite
11/16/2005	EP1594877A2 Process for the production of 2-oxa-3-one androstane derivatives
10/2005
10/06/2005	US20050222109 Crystalline 19-norsteroids
09/2005
09/14/2005	CN1668632A Method for introducing a 1, 2 double bond into 3-oxo-4-azasteroid compounds
08/2005
08/24/2005	EP1504019B1 Platinum complexes having antitumor activity
08/10/2005	CN1653082A Platinum complexes having antitumor activity
08/09/2005	CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
07/2005
07/20/2005	CN1642558A Theraputic methods and uses of sapogenins and their derivatives
06/2005
06/16/2005	US20050130948 Therapeutic methods and uses of sapogenins and their derivatives
06/02/2005	US20050118242 Using testosterone; topical applying to skins
05/2005
05/26/2005	WO2005000245A3 Compositions and methods for increasing telomerase activity
05/19/2005	US20050107337 Platinum complexes having antitumor activity
04/2005
04/28/2005	US20050090663 Carbonylation; hydrogenation; epoxidation; alkynylation; for preparation of eplerenone
04/20/2005	EP1523490A1 Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds
03/2005
03/24/2005	US20050065135 Contraceptives; side effect reduction; antitumor, anticancer agents
03/08/2005	US6863865 Sterilization of pharmaceuticals
02/2005
02/24/2005	WO2004089970A3 Crystalline 19-norsteroids
02/17/2005	WO2004074305A3 Process for the production of 2-oxa-3-one androstane derivatives
02/16/2005	CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances
02/09/2005	EP1504019A1 Platinum complexes having antitumor activity
02/03/2005	WO2004085457A3 17beta-hydroxysteroid dehydrogenase inhibitors
02/03/2005	US20050026888 Formulation containing anti-inflammatory androstane derivatives
01/2005
01/06/2005	WO2005000245A2 Compositions and methods for increasing telomerase activity
01/05/2005	CN1561217A Estrogen/gestagen combination preparation and application thereof
01/05/2005	CN1183154C Solid dispersion containing sialic acid derivative
12/2004
12/30/2004	US20040266745 Estrogen-gestagen combination preparations and uses thereof
12/23/2004	WO2004094451A3 8&dollar;G(B)-VINYL-11&dollar;G(B)-(&dollar;G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES
12/16/2004	WO2004089969A3 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
11/2004
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	DE10318896A1 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene 8beta-vinyl-11beta- (omega-substituted) alkyl-estra-1,3,5 (10) -trienes
11/18/2004	US20040230062 reacting androstane-3-one derivative with ozone
11/18/2004	US20040228935 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
11/11/2004	US20040225139 a 3-oxo-androstrane carbothioic acid compound
11/11/2004	US20040224934 3 -oxo-androstrane carbothioic acid compound
11/11/2004	US20040224931 3-oxo-androstrane carbothioic acid compound
11/04/2004	WO2004094451A2 8&dollar;G(B)-VINYL-11&dollar;G(B)-(&dollar;G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES
11/04/2004	US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/04/2004	US20040220157 a 3-oxoandrostrane carbothioic acid compound
11/04/2004	US20040219174 Contraception process and administration form for the same
11/04/2004	CA2522354A1 8beta-vinyl-11beta-(alpha-substituted)alkyl-estra-1,3,5(10)-trienes
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
10/2004
10/21/2004	WO2004089970A2 Crystalline 19-norsteroids
10/21/2004	WO2004089969A2 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
10/21/2004	CA2521120A1 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
10/14/2004	WO2004087731A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates
10/14/2004	CA2530680A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates
10/07/2004	WO2004085458A2 Steroid spirolactonization
10/07/2004	WO2004085457A2 17beta-hydroxysteroid dehydrogenase inhibitors
10/07/2004	CA2519770A1 Steroid spirolactonization
09/2004
09/16/2004	WO2004078774A1 Process for the production of tibolone
09/16/2004	CA2517934A1 Process for the production of tibolone
09/08/2004	EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
09/02/2004	WO2004074305A2 Process for the production of 2-oxa-3-one androstane derivatives
09/02/2004	CA2515697A1 Process for the production of 2-oxa-3-one androstane derivatives
08/2004
08/03/2004	US6770768 Lowers ldl cholesterol levels in serum and which is fat soluble beta - sitostanol fatty acid ester, and to a method for preparing and using the same. the substance can be taken orally as a food additive, food substitute or supplement.
07/2004
07/21/2004	EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite
07/07/2004	EP1434586A1 Estrogen/gestagen combination preparation and application thereof
04/2004
04/15/2004	WO2003082893A3 Theraputic methods and uses of sapogenins and their derivatives
04/08/2004	US20040067921 Anticholesterol agents
03/2004
03/17/2004	CN1142175C Sulfurization for oestrogen mixture
02/2004
02/05/2004	US20040023936 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
01/2004
01/29/2004	US20040019026 Compounds useful for treating hypertriglyceridemia
01/27/2004	CA2166089C 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof
01/22/2004	WO2004007523A1 Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds
01/22/2004	CA2497611A1 Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds
01/01/2004	US20040002482 Androgen pharmaceutical composition and method for treating depression
12/2003
12/31/2003	WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives
12/03/2003	CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
11/2003
11/20/2003	WO2003095470A1 Platinum complexes having antitumor activity
11/20/2003	CA2485431A1 Platinum complexes having antitumor activity
11/12/2003	CN1455681A Contraception process and administration for same
10/2003
10/15/2003	EP1351971A2 Compounds useful for treating hypertriglyceridemia
10/09/2003	WO2003082893A2 Theraputic methods and uses of sapogenins and their derivatives
10/02/2003	US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
09/2003
09/16/2003	US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
09/02/2003	US6613929 Reacting a corresponding chloroformate of with an alkali metal fluoride in ethylene carbonate at a temperature wherein the ethylene carbonate is liquid; much shorter reaction times
08/2003
08/27/2003	EP1337279A1 Sterilisation of pharmaceuticals
07/2003
07/17/2003	US20030134833 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
06/2003
06/26/2003	WO2003051371A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
06/26/2003	US20030120103 Process for preparation of fluoroformates
06/25/2003	EP1321451A1 Process for the preparation of fluoroformates
06/11/2003	EP1317286A2 Contraception process and administration form for the same

1 2 3 4 5